Sean Dodge
Stock Analyst at RBC Capital
(2.00)
# 3,013
Out of 4,911 analysts
133
Total ratings
31.96%
Success rate
-3.49%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.88 | +54.64% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.06 | +69.90% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $199.17 | +35.56% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.20 | +46.34% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $187.01 | +40.63% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $9.93 | +71.20% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $26.63 | +20.17% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $14.36 | -58.22% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $96.04 | +9.33% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $12.31 | +38.10% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $35.83 | -5.11% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $23.38 | -40.11% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $5.00 | +100.00% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $19.71 | +42.10% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $13.27 | +5.54% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $187.12 | -82.36% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $0.58 | +30,706.09% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.88
Upside: +54.64%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.06
Upside: +69.90%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $199.17
Upside: +35.56%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.20
Upside: +46.34%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $187.01
Upside: +40.63%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.93
Upside: +71.20%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $26.63
Upside: +20.17%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $14.36
Upside: -58.22%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $96.04
Upside: +9.33%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $12.31
Upside: +38.10%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $35.83
Upside: -5.11%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $23.38
Upside: -40.11%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $5.00
Upside: +100.00%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $19.71
Upside: +42.10%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $13.27
Upside: +5.54%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $187.12
Upside: -82.36%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $0.58
Upside: +30,706.09%